What Does It Mean When a Sample Is Hemolyzed?

A hemolyzed sample is one in which red blood cells have ruptured, spilling their internal contents into the liquid portion of the blood. This matters because those released substances contaminate the sample and can throw off lab test results, sometimes dramatically. The problem is overwhelmingly caused by errors in how blood is drawn, handled, or transported rather than by anything going on inside the patient’s body. Understanding what hemolysis means, which results it distorts, and why your doctor might ask for a second draw can save you both confusion and unnecessary worry.

What Actually Happens Inside a Hemolyzed Sample

Red blood cells are essentially tiny bags filled with hemoglobin, potassium, enzymes, and other molecules that are supposed to stay inside the cell. When those cells break open, all of that material floods into the plasma or serum surrounding them. The sample takes on a reddish or pinkish tinge from the freed hemoglobin, which is the visual hallmark lab staff look for. But the color change is just the visible part. The chemical contamination underneath is what actually causes problems for test accuracy.

Cells can be lysed through several physical and chemical mechanisms: freezing and thawing, osmotic shock (exposure to a solution that causes them to swell and burst), and shear stress from physical force during collection or transport.¹ In a clinical setting, shear stress is the most common culprit. Think of it as red blood cells being squeezed through too-small openings, sloshed around too violently, or subjected to sudden pressure changes. The cells are fragile, and it does not take much to break them.

Why It Usually Happens During Blood Collection

The vast majority of hemolyzed samples trace back to what labs call the “pre-analytical phase,” meaning everything that happens before the sample reaches the analyzer. And the single biggest variable is how the blood was drawn in the first place.

Several collection-related factors reliably increase hemolysis rates. Drawing blood through an intravenous catheter rather than a dedicated venipuncture produces far more hemolyzed samples. The same is true when blood is drawn from a site other than the inside of the elbow, when the tourniquet stays on for more than a minute, when collection tubes are less than half full, and when the person drawing the blood is not a trained phlebotomist.² That last point is a consistent finding across studies. When hospitals shifted routine blood draws from dedicated phlebotomy teams to nurses and resident physicians, hemolysis rates climbed, driven primarily by the lack of specialized skill and repetitive practice.³

Emergency departments are the worst-hit setting. The combination of urgency, difficult IV access, and blood frequently drawn through catheters rather than clean venipunctures creates a perfect storm for hemolysis. A systematic review and meta-analysis found that using a fresh straight-needle venipuncture instead of pulling blood from an IV line reduced hemolysis dramatically, with roughly an 84% lower risk on average. Drawing from the antecubital fossa (the inside of the elbow) rather than other sites cut hemolysis risk by about half.⁴

How Transport and Handling Add to the Problem

Even a perfectly drawn sample can end up hemolyzed if it is handled roughly on the way to the lab. Many hospitals use pneumatic tube systems to shoot samples through pressurized tubes across the building. These systems save time, but the high transport speed, sudden changes in direction, rapid acceleration and deceleration, and pressure fluctuations can all damage red blood cells.⁵ One study comparing transport methods found that while about 10% of hand-carried samples exceeded hemolysis thresholds, samples sent through a pneumatic tube system with switches (the type that redirects capsules at junctions) had a hemolysis rate of 47%.⁶

That does not mean all pneumatic tube systems are equally bad. Systems that have been validated and maintained properly can transport samples without excessive hemolysis, while older or more complex systems with multiple switching points are the bigger offenders. Still, the evidence clearly supports that hand transport or courier delivery is gentler on samples when it is logistically feasible.⁷

Which Lab Results Get Distorted

Hemolysis does not affect every test equally. Some results become wildly inaccurate, others shift only slightly, and a few are barely touched. The direction of the error matters too: hemolysis can push a result falsely high or falsely low depending on the test.

The single most clinically important interference is with potassium. Red blood cells contain potassium at concentrations many times higher than what circulates in plasma. When those cells rupture, potassium floods into the sample, producing a falsely elevated reading.⁸ This is not a trivial distortion. Potassium levels guide major clinical decisions including cardiac monitoring and treatment of kidney disease. A falsely high potassium reading from hemolysis can trigger unnecessary interventions, while the true potassium level remains unknown until a clean sample is collected.

Liver enzymes are another problem area. Lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) both exist in high concentrations inside red blood cells. When hemolysis releases them into the sample, these values spike artificially, which can mimic or exaggerate the appearance of liver damage, heart injury, or tissue breakdown.¹ Laboratories have explored correction algorithms for AST and LDH in mildly hemolyzed samples, but the reliability of these corrections is limited and not universally adopted.⁹ Phosphate is also pushed upward by hemolysis, along with several other intracellular molecules.

Then there are the tests that hemolysis pushes in the other direction. Free hemoglobin absorbs light at specific wavelengths, and because many modern lab analyzers measure substances by shining light through a sample, that extra color can interfere with spectrophotometric readings. The interference can either add to or subtract from the signal the analyzer is trying to detect, depending on the specific chemistry involved.

Cardiac Troponin and Clotting Tests

One of the more dangerous interference patterns involves cardiac troponin T, a protein measured when doctors suspect a heart attack. Hemolysis causes troponin T readings to drop rather than rise. Research indicates that the rupture of red blood cells releases proteases (enzymes that chop up proteins), and those proteases degrade the troponin T in the sample. At a hemoglobin level of just 0.75 grams per liter from hemolysis, troponin T levels fell by more than 10% of the initial concentration.¹⁰ In a clinical scenario where a borderline troponin result could determine whether a patient is admitted for a possible heart attack or sent home, a falsely lowered result from hemolysis is a serious safety concern.

Clotting tests are also affected. Prothrombin time (PT) and activated partial thromboplastin time (aPTT), which measure how quickly blood clots and are critical for managing patients on blood thinners, can both shift in the presence of hemolysis. Mild hemolysis tends to shorten aPTT, making clotting appear faster than it really is. The relationship between hemolysis severity and the degree of interference varies, but even mild hemolysis reached statistical significance for aPTT changes.¹¹

How the Lab Detects Hemolysis

Laboratories use two main approaches to flag hemolysis: looking at the sample and measuring it with an instrument. The traditional method is visual inspection, where a lab technician examines the serum or plasma for a reddish or pink tinge. This works reasonably well for catching moderate to severe hemolysis, but it is subjective and unreliable for borderline cases.

The more modern approach is the hemolysis index (HI), an automated measurement built into most contemporary chemistry analyzers. The instrument shines light through the sample at specific wavelengths and calculates how much free hemoglobin is present. This gives a quantitative number rather than a subjective color impression. When researchers compared the two methods, visual assessment classified nearly all samples as non-hemolyzed, while the instrument-based hemolysis index caught additional rejectable samples, particularly for potassium, phosphate, and liver enzymes. The discrepancies between the two methods exceeded half a percent for commonly tested analytes, which matters at the scale of a busy hospital lab processing thousands of samples daily.¹²

Blood gas analyzers present their own challenge. These instruments, often located at the bedside or in the emergency department rather than the central lab, historically lacked the ability to detect hemolysis at all. Since blood gas samples are whole blood rather than separated serum, visual inspection is not possible either. Hemolysis in blood gas samples is reported to occur in roughly 1% to 13% of specimens depending on the setting.¹³ Newer point-of-care analyzers have started incorporating hemolysis detection. One study at an emergency department found hemolysis in about 8% of blood gas samples, and a point-of-care hemolysis detection method identified those samples with 80% sensitivity and 99% specificity.¹⁴

What Happens When Your Sample Gets Flagged

When the lab flags a sample as hemolyzed, several things can happen depending on the degree of hemolysis and the specific tests ordered. Mild hemolysis might prompt the lab to release certain results that are not significantly affected (like sodium or chloride) while withholding others that are (like potassium or LDH). Moderate to severe hemolysis typically triggers rejection of the entire sample for susceptible tests, and a new blood draw is requested.

How labs set their rejection thresholds is not standardized across institutions. Guidelines recommend that laboratory directors work with clinical teams to define, on a test-by-test basis, the level of mild hemolysis that triggers a warning flag on the reported result and the level of significant hemolysis at which results should not be reported at all.¹⁵ This means two hospitals may handle the same hemolyzed sample differently, which is an acknowledged gap in laboratory practice.

The decision to reject or report a hemolyzed result also depends on the clinical context. A patient in critical condition who would be endangered by delay in getting any result at all presents a harder case than a routine outpatient check. Labs sometimes release mildly hemolyzed results with a comment noting the interference, leaving the interpreting physician to factor that into their clinical judgment. Whether to reject outright or release with a disclaimer remains an area of ongoing debate.¹⁶

When Hemolysis Reflects a Real Medical Condition

In a small fraction of cases, hemolysis in a blood sample is not an artifact of collection at all. It reflects actual red blood cell destruction happening inside the patient’s body, known as in vivo hemolysis. Conditions like autoimmune hemolytic anemia, sickle cell crises, transfusion reactions, severe infections, and certain toxin exposures genuinely destroy red blood cells in the bloodstream. When that is the case, the hemolysis is not a problem with the sample but rather a finding in itself.

Telling the two apart matters clinically. If in vivo hemolysis is mistaken for a collection error and the result is discarded, a genuine diagnosis could be delayed. Differentiating in vivo from in vitro hemolysis requires looking at the broader clinical picture: does the patient have signs or symptoms of hemolytic disease? Are other markers of red cell breakdown elevated? Is there a plausible pre-analytical explanation? Laboratories are encouraged to use systematic approaches to distinguish between the two, including relying on the hemolysis index and clinical history provided by the ordering physician.¹⁷ If you have a known hemolytic condition and your lab calls about a hemolyzed sample, mentioning your diagnosis can help the lab handle the result correctly.

The Cost of Getting It Wrong

Hemolyzed samples are not just a quality-control headache. They carry real financial and patient-care consequences, particularly in emergency departments where the problem is most common. When a hemolyzed sample is rejected, the patient needs a new blood draw, which means another needle stick, more time waiting for results, and a longer stay in the ED. One analysis estimated that for an emergency department seeing 100,000 visits per year with a 10% hemolysis rate, the direct cost of hemolysis-related delays reached roughly $4 million annually, driven by an average of one additional hour of ED length of stay per affected patient.¹⁸

Those costs extend beyond the financial. A patient waiting an extra hour for results because their first sample was hemolyzed is a patient whose diagnosis is delayed, whose bed is occupied instead of available, and whose experience of care is worse. In trauma settings, where rapid lab results directly guide resuscitation decisions, hemolyzed samples can delay critical blood type matching and transfusion.³

How Hospitals Work to Prevent It

Given the scale of the problem, hospitals and laboratories have tested a range of interventions. The evidence consistently points to a handful of practical measures that make the biggest difference:

Dedicated venipuncture: Drawing blood with a fresh needle directly into a vein, rather than pulling it from an existing IV line, is the single most effective intervention. Studies consistently show hemolysis drops by about 84% when this practice is followed.
Antecubital draw site: Blood drawn from the inside of the elbow hemolyzes less than blood drawn from the back of the hand or other peripheral sites, likely because the veins are larger and allow less turbulent blood flow.
Professional phlebotomists: Deploying trained blood-draw specialists, especially in emergency departments, reduces hemolysis rates compared with having nurses or physicians draw blood as a secondary task.
Appropriate tube filling: Tubes that are less than half full hemolyze more, likely because the vacuum-to-blood ratio causes excessive force on the cells.
Tourniquet time under one minute: Prolonged tourniquet application increases hemolysis, so releasing the tourniquet promptly matters.

All of these findings come from a large body of evidence spanning more than 40 studies.² On the transport side, hospitals that validate their pneumatic tube systems and use gentler transport for sensitive specimens can reduce transport-related hemolysis. Some institutions have moved to hand-carrying certain high-priority specimens rather than tubing them.

Hemolysis in Newborns and Capillary Samples

Newborns and very small infants present a unique hemolysis challenge. Their blood is typically collected via heel sticks rather than venipuncture, and the small sample volumes and collection technique make hemolysis more likely. One study comparing collection devices in neonates found that samples collected with a manual hand-held lance had more than double the free hemoglobin concentration compared with those collected using an automated incision device. Mean hemoglobin released into the sample was 4.85 g/L with the manual lance versus 2.35 g/L with the automated device.¹⁹ The implication is practical: hospitals that standardize capillary collection with automated incision devices can meaningfully reduce hemolysis in their smallest patients, where repeat blood draws are especially undesirable.

Hemolysis in Veterinary Medicine

The hemolysis problem is not unique to human medicine. Veterinary laboratories face similar challenges, and the list of affected tests overlaps substantially with what is seen in human samples. A study in cattle found that artificially induced hemolysis significantly altered 8 of 14 key biochemistry parameters, with calcium and total bilirubin falling at moderate hemolysis levels while albumin and cholesterol rose at higher levels.²⁰ Veterinary blood draws carry their own pre-analytical risks: animals may struggle during collection, sample volumes are sometimes small relative to tube size, and transport from farm to laboratory can involve rough road conditions. The underlying physics of cell rupture and chemical contamination is the same across species, which means that similar prevention strategies apply.

1
Europe PMC. Methods for Hemolysis Interference Study in Laboratory Medicine – A Critical Review
2
PubMed. Key factors influencing the incidence of hemolysis: A critical appraisal of current evidence
3
Europe PMC. A retrospective analysis of the incidence of hemolysis in type and screen specimens from trauma patients
4
PubMed Central. Effectiveness of practices to reduce blood sample hemolysis in EDs: A laboratory medicine best practices systematic review and meta-analysis
5
PubMed Central. Hemolysis associated with pneumatic tube system transport for blood samples
6
PubMed. The Effect of Pneumatic Tube Systems on the Hemolysis of Biochemistry Blood Samples
7
Clinical Chemistry. Determination of Hemolysis Thresholds by the Use of Data Loggers in Pneumatic Tube Systems
8
The Journal of Applied Laboratory Medicine. Correcting Potassium Concentrations Measured in Hemolyzed Serum, Plasma, and Whole Blood Samples
9
SAGE Journals / Annals of Clinical Biochemistry. Design, validation and performance of aspartate aminotransferase- and lactate dehydrogenase-reporting algorithms for haemolysed specimens including correction within quality specifications
10
PubMed. Mechanism of interference by haemolysis in the cardiac troponin T immunoassay
11
Europe PMC. The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
12
PubMed. Comparison of Visual Assessment and Hemolysis Index in Detecting Hemolysis across Common Biochemical Assay: Implications for Sample Rejection in Clinical Laboratory Practice
13
PubMed Central. Improved potassium reliability in whole blood through hemolysis detection on the novel GEM Premier 7000 blood gas analyzer
14
PubMed. Point-of-care hemolysis detection in blood gas specimens directly at the emergency department
15
The Journal of Applied Laboratory Medicine. Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action
16
PubMed Central. Hemolyzed Specimens: Major Challenge for Identifying and Rejecting Specimens in Clinical Laboratories
17
PubMed. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories
18
The Journal of Applied Laboratory Medicine. The Hidden Cost of Hemolyzed Blood Samples in the Emergency Department
19
JAMA Pediatrics. Comparison of Hemolysis in Blood Samples Collected Using an Automatic Incision Device and a Manual Lance
20
PubMed Central. Influence of haemolysis on blood biochemistry profiles in cattle